Baker Daniel G. has filed 6 insider transactions across 3 companies since November 2024.
Most recent transaction: a grant/award of 50000 shares of Cue Biopharma, Inc. ($CUE) on September 29, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 29, 2025 | Cue Biopharma, Inc. | $CUE | Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 56,328,348 | 9999.99% | 0.09% |
| Aug. 28, 2025 | Shattuck Labs, Inc. | $STTK | Baker Daniel G. | Not found | A | Stock Option (Right to Buy) | 66300 | $0.00 | 66,300.0000 | 50,758,290 | 9999.99% | 0.13% |
| June 24, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Baker Daniel G. | Not found | A | Director Stock Option (Right to Buy) | 13750 | $0.00 | 13,750.0000 | 24,363,119 | 9999.99% | 0.06% |
| March 21, 2025 | Cue Biopharma, Inc. | $CUE | Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 56,328,348 | 9999.99% | 0.18% |
| Jan. 28, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Baker Daniel G. | Not found | A | Director Stock Option (Right to Buy) | 27500 | $0.00 | 27,500.0000 | 0 | 9999.99% | 0.00% |
| Nov. 25, 2024 | Cue Biopharma, Inc. | $CUE | Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | A | Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 51,229,701 | 9999.99% | 0.39% |